Risk of End-Stage Renal Disease Low With Type 1 Diabetes
Findings among a large study of Norwegian children followed for 40-plus years
Vaccination Coverage High for Children Aged 19 to 35 Months
And 2013 to 2016 saw progress being made toward immunization information systems program goals
Benefits for New Immunoassays for Measuring Aβ42 in CSF
May show improved correlation with mass spectrometry reference measurement procedure
Adipocytes Metabolize, Inactivate Daunorubicin
Adipocytes metabolize daunorubicin to daunorubicinol, reducing its anti-leukemia effect
Eclampsia Tied to Increased Relative Risk of Seizure Disorder
However, the risk remains extremely low, at 4.58/10,000 person-years
Breast Cancer Recurrences Steady After Therapy Cessation
Women with ER-positive BC who stop therapy after 5 years have steady recurrence rate up to 20 years
Doctors Have Extra Two Weeks to Preview Performance Data
Due to technical issue with Physician Compare, CMS extending time frame for physicians to view data
Drop in Incidence of End-Stage Renal Disease Due to Diabetes
2000 to 2014 saw decrease in incidence of ESRD with diabetes listed as the primary cause
Lymphoma Risk Up With Thiopurine, Anti-TNF Tx in IBD
Risk higher for those exposed to combination therapy versus thiopurine or anti-TNF monotherapy
Increases in U.S. Health Spending Tied to Health Service Price
Higher spending also linked to population growth and aging, negatively linked to disease incidence
